Tweet
I want to use BowTie. I download it and run the example commands given into it. However, I want to build index for read length 150 bps. This command (/.bowtie-build chromosome1.fa bowtieIndex ) seems gives default index bilder means for 36 bps. Can anybody help me how to build BowTie index for 150 bps.
-
Last edited by Arupsss; 06-18-2012, 11:15 AM. -
I'm no expert, but ... I think ..
The index built for your genome (or chromosome) should be able to handle varying sized read lengths as input to bowtie when doing alignment. The index is not specific to the read lengths that you are trying to align.
The introduction in the bowtie documentation mentions an example 36bp test file. The build is not made from this test file, it's just test data made from the genome (or chromsome). If you need 150bp test data ... well, that's another problem ... likely requiring a little custom scripting. -
Richard is right, the bowtie index can handle multiple read lengths. It even works when you have a mixed length of reads. However, I would recommend bowtie2 over bowtie, particularly for the longer read lengths.Comment
-
You build the index for the reference genome (and not for a particular type/length of reads).
I think you may be confused by the wording in the first para here (http://bowtie-bio.sourceforge.net/ma...what-is-bowtie). The 36-bp is a historical reference to the original read length for illumina reads (which have since been lengthened to 150 bp or more).Last edited by GenoMax; 06-19-2012, 08:19 AM.Comment
-
index for viral genome
I want to run TopHAt of viral genome but to make it compatible I guess I need to generate index could some one guide me how can I generate such index files. Is there any web based tool or it is just only possibly only by programming. The particular genome is not available of tophat/ bowtie web page.
ThanksComment
-
For Tophat: http://bowtie-bio.sourceforge.net/ma...-build-indexerOriginally posted by mathew View Post
For Tophat2: http://bowtie-bio.sourceforge.net/bo...-build-indexerComment
-
Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.
The systematic characterization of the human proteome has...07-20-2026, 11:48 AM -
Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...07-09-2026, 11:10 AM -
Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.
There is no single reason why many patients don’t respond to treatment as expected. Cancer is...07-08-2026, 05:17 AM
Comment